Center for the Study of Systems Biology

  • Home
  • About us
    • Members
  • Skolnick Research Group
    • Jeffrey Skolnick
    • Maximilian Brogi
    • Brendon Cara
    • Chad Choudhry
    • Brice Edelman
    • Jonathan Feldman
    • Jessica Gilmore Forness
    • Bartosz Ilkowski
    • Preetam Jukalkar
    • Giselle McPhilliamy
    • Asha Mira Rao
    • Hargobind Singh
    • Kyle Xu
    • Hongyi Zhou
    • Former Group Members
  • Publications
    • Publications
    • Preprints
  • Software and Services
    • Services
      • DESTINI
      • DR. PRODIS
      • ENTPRISE
      • ENTPRISE-X
      • FINDSITEcomb
      • FINDSITEcomb2.0
      • FRAGSITE
      • FRAGSITE2
      • FRAGSITEcombM
      • Know-GENE
      • LeMeDISCO
      • MEDICASCY
      • MOATAI-VIR
      • PHEVIR
      • PICMOA
    • Downloads
      • AF2Complex
      • AF3Complex
      • APoc
      • Cavitator
      • DBD-Hunter
      • DBD-Threader
      • EFICAz2.5
      • Fr-TM-align
      • GOAP
      • iAlign
      • IS-score
      • LIGSIFT
      • MENDELSEEK
      • PULCHRA
      • SAdLSA
      • Valsci
    • Databases
      • Apo and Holo Pairs
      • New Human GPCR Modeling and Virtual Screening
      • PDB-like Structures
    • Simulations
      • E. coli Intracellular Dynamics
  • News & Events
    • News
    • ARCHIVE: Distinguished Lecture Series in Systems Biology
  • Jobs

Table S2.

Hierarchically ranked comorbidities, comorbidity enriched MOA proteins, pathways and the top 20 drugs for each COVID-19 clinical manifestation from the GWAS risk genes2 as input results.

Clinical manifestationComorbiditiesComorbidity enriched MOA proteinsPathways | Top pathwaysCoMOAdrug drugsCoVLS drugs
Neurologiccongenital myasthenic syndrome
myotonia congenita
facial neuralgia
Charcot-Marie-Tooth disease type 2
idiopathic peripheral autonomic neuropathy
multiple system atrophy
autonomic nervous system disease
Lambert-Eaton myasthenic syndrome
peripheral nervous system disease
movement disease
focal hand dystonia
complex regional pain syndrome
femoral neuropathy
lingual-facial-buccal dyskinesia
Riley-Day syndrome
Parkinson's disease
reflex sympathetic dystrophy
Huntington's disease
spastic quadriplegia
spastic monoplegia
Parkinson's disease 23
Parkinson's disease 4
Parkinson's disease 19A
sleep disorder
anterior horn cell disease
critical illness polyneuropathy
generalized dystonia
dystonia
nervous system disease
Alzheimer's disease
encephalomalacia
migraine with aura
early myoclonic encephalopathy
Lewy body dementia
motor neuron disease
restless legs syndrome
lateral sclerosis
muscular atrophy
carpal tunnel syndrome
neurodegenerative disease
chronic fatigue syndrome
facioscapulohumeral muscular dystrophy
pantothenate kinase-associated neurodegeneration
dentatorubral-pallidoluysian atrophy
progressive myoclonus epilepsy
Unverricht-Lundborg syndrome
epilepsy
narcolepsy
neuroleptic malignant syndrome
multiple sclerosis
neurodegeneration with brain iron accumulation 6
neurodegeneration with brain iron accumulation 5
neurodegeneration with brain iron accumulation 4
neurodegeneration with brain iron accumulation 2b
neurodegeneration with brain iron accumulation 2a
Huntington's disease-like 2
Huntington's disease-like 1
torsion dystonia with onset in infancy
X-linked dystonia-parkinsonism
dystonia 12
dystonia 25
episodic kinesigenic dyskinesia 2
episodic kinesigenic dyskinesia 1
dystonia 24
dystonia 23
dystonia 27
striatonigral degeneration
paroxysmal nonkinesigenic dyskinesia 1
dystonia 16
paroxysmal nonkinesigenic dyskinesia 2
dystonia 21
childhood onset GLUT1 deficiency syndrome 2
dystonia 9
dystonia 5
torsion dystonia 17
torsion dystonia 4
torsion dystonia 6
torsion dystonia 2
torsion dystonia 13
myoclonic dystonia 11
syndromic X-linked intellectual disability type 10
benign shuddering attacks
postencephalitic Parkinson disease
torsion dystonia 1
hyperekplexia 3
hyperekplexia 2
hyperekplexia 1
hyperekplexia
extrapyramidal and movement disease
secondary Parkinson disease
choreatic disease
sleep apnea
blepharospasm
obstructive sleep apnea
epilepsy with generalized tonic-clonic seizures
reflex epilepsy
juvenile spinal muscular atrophy
migraine
focal epilepsy
childhood absence epilepsy
essential tremor
C5orf52
L3HYPDH
SV2A
DNPEP
RNPEP
SV2B
GATM
ACYP1
FBXO31
ACYP2
LANCL3
CCL8
TXNDC12
SV2C
PARS2
ATXN3
OR2A1
SEC31A
GSTT2
GGT6
Glutathione conjugation | Metabolism
Na+/Cl- dependent neurotransmitter transporters | Transport of small molecules
G-protein activation | Signal transduction
G beta:gamma signalling through BTK | Signal transduction
G beta:gamma signalling through CDC42 | Signal transduction
G beta:gamma signalling through PLC beta | Signal transduction
Prostacyclin signalling through prostacyclin receptor | Hemostasis
Presynaptic function of Kainate receptors | Neuronal system
ADP signalling through P2Y purinoceptor 12 | Hemostasis
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | Disease
Toxicity of botulinum toxin type D (botD) | Disease
Toxicity of botulinum toxin type F (botF) | Disease
Transport of the SLBP independent Mature mRNA | Metabolism of RNA
SUMOylation of SUMOylation proteins | Metabolism of proteins
Thromboxane signalling through TP receptor | Hemostasis
G beta:gamma signalling through PI3Kgamma | Signal transduction
ADP signalling through P2Y purinoceptor 1 | Hemostasis
Transport of the SLBP Dependant Mature mRNA | Metabolism of RNA
Regulation of Glucokinase by Glucokinase Regulatory Protein | Metabolism
Nuclear import of Rev protein | Disease
Nuclear Pore Complex (NPC) Disassembly | Cell cycle
G protein gated Potassium channels | Neuronal system
Activation of G protein gated Potassium channels | Neuronal system
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | Neuronal system
Toxicity of botulinum toxin type A (botA) | Disease
SUMOylation of ubiquitinylation proteins | Metabolism of proteins
Adrenaline,noradrenaline inhibits insulin secretion | Metabolism
Transport of Mature mRNA derived from an Intron-Containing Transcript | Metabolism of RNA
Vpr-mediated nuclear import of PICs | Disease
Rev-mediated nuclear export of HIV RNA | Disease
Activation of kainate receptors upon glutamate binding | Neuronal system
Transport of Mature mRNA Derived from an Intronless Transcript | Metabolism of RNA
Interactions of Rev with host cellular proteins | Disease
NS1 Mediated Effects on Host Pathways | Disease
Thrombin signalling through proteinase activated receptors (PARs) | Hemostasis
Glucagon-type ligand receptors | Signal transduction
Transport of Mature mRNAs Derived from Intronless Transcripts | Metabolism of RNA
Interactions of Vpr with host cellular proteins | Disease
Transport of Ribonucleoproteins into the Host Nucleus | Disease
Transport of Mature Transcript to Cytoplasm | Metabolism of RNA
SUMOylation of DNA replication proteins | Metabolism of proteins
Inwardly rectifying K+ channels | Neuronal system
SUMOylation of RNA binding proteins | Metabolism of proteins
Codeine*
Paliperidone*
Prasterone*
Trihexyphenidyl*
Prednisolone*$
Naltrexone*$
Temazepam*
Methylscopolamine bromide
Orphenadrine*
Pravastatin
Medrogestone
Drostanolone
Estriol
Mepivacaine*
Alprazolam*
Tetrahydrofolic acid
Imipramine*
Pomalidomide
Flurazepam*
Triazolam*
Amphetamine*
Mephentermine
Modafinil*
Ipratropium bromide
Trihexyphenidyl*
Levomethadyl Acetate
Imipramine*
Methadone*
Drostanolone
Gadobutrol
Naltrexone*$
Tiagabine
Pseudoephedrine*
Pipobroman
Fluvoxamine*$
Felbamate
Levonorgestrel*
Nateglinide
Methyldopa*
Butabarbital
Cardiovascular/Arrhythmiacarotid stenosis
brain ischemia
renal artery disease
acute anterolateral myocardial infarction
acute inferolateral myocardial infarction
acute inferoposterior infarction
subendocardial infarction acute myocardial infarction
strictly posterior acute myocardial infarction
arrhythmogenic right ventricular cardiomyopathy
myocardial stunning
arteriosclerosis obliterans
left bundle branch hemiblock
mitral valve stenosis
Dressler's syndrome
aortic aneurysm
abdominal aortic aneurysm
intracranial embolism
aortic valve insufficiency
long QT syndrome
peripheral vascular disease
lymphedema
thromboangiitis obliterans
cardiac arrest
thoracic aortic aneurysm
intermediate coronary syndrome
cardiovascular system disease
acute myocardial infarction
congestive heart failure
myocardial infarction
heart disease
hypertensive heart disease
secondary hypertension
cerebral arterial disease
essential hypertension
coronary artery disease
cerebrovascular disease
pulmonary embolism and infarction
aortic disease
atrial fibrillation
renovascular hypertension
nephrosclerosis
dilated cardiomyopathy
coronary artery vasospasm
ischemia
hypertension
systolic heart failure
heart valve disease
cardiomyopathy
atrioventricular block
varicose veins
hypertrophic cardiomyopathy
APLNR
ADRB3
PTGDR2
OR52B4
F2RL2
GPR25
ADRB2
TACR2
OR5M1
GALR1
CXCR6
XCR1
SUCNR1
OR13A1
TAAR6
OR5M10
OR52N2
BRS3
GPR149
KISS1R
Class A/1 (Rhodopsin-like receptors) | Signal transduction
GPCR ligand binding | Signal transduction
Peptide ligand-binding receptors | Signal transduction
GPCR downstream signalling | Signal transduction
Signaling by GPCR | Signal transduction
ADORA2B mediated anti-inflammatory cytokines production | Disease
Amine ligand-binding receptors | Signal transduction
G alpha (s) signalling events | Signal transduction
Anti-inflammatory response favouring Leishmania parasite infection | Disease
Leishmania parasite growth and survival | Disease
Adrenoceptors | Signal transduction
G alpha (i) signalling events | Signal transduction
Olfactory Signaling Pathway | Signal transduction
Tachykinin receptors bind tachykinins | Signal transduction
Leishmania infection | Disease
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | Disease
G alpha (q) signalling events | Signal transduction
Codeine*
Trandolapril*
Acarbose*
Prasterone
Ramipril*$
Prednisolone*$
Enalapril*
Pravastatin*
Betaxolol
Paliperidone
Reserpine*
Caffeine*
Nimodipine
Pindolol
Estriol
Olmesartan*
Medrogestone
Temazepam
Trihexyphenidyl
Orphenadrine
Modafinil
Mephentermine
Salbutamol*
Imipramine*
Amphetamine*
Orciprenaline
Tolazoline
Pinaverium
Betaxolol
Epirubicin
Naltrexone*$
Timolol
Trihexyphenidyl
Drostanolone
Pseudoephedrine
Levonorgestrel
Oxprenolol
Nimodipine
Citalopram*
Tiagabine
Endocrineobsolete Cushing's syndrome
nodular goiter
hyperinsulinemic hypoglycemia
alpha 1-antitrypsin deficiency
hyperthyroidism
adrenal gland hyperfunction
Addison's disease
premature menopause
premature ovarian failure
phenylketonuria
empty sella syndrome
diabetic polyneuropathy
familial hyperlipidemia
diabetes mellitus
non-renal secondary hyperparathyroidism
diabetic neuropathy
morbid obesity
primary hyperaldosteronism
Conn's syndrome
adrenal cortical hypofunction
type 2 diabetes mellitus
diabetic retinopathy
hyperlipoproteinemia type IV
hypoglycemia
familial partial lipodystrophy
cerebrotendinous xanthomatosis
xanthomatosis
glycine encephalopathy
hypothyroidism
amino acid metabolic disorder
hypogonadism
hyperinsulinism
abdominal obesity-metabolic syndrome 1
obesity
pellagra
ariboflavinosis
beriberi
COX7A1
COX7A2L
COX7A2
ELOVL7
ELOVL1
SLC8A3
NR4A3
ELOVL4
CELA2B
SLC8A1
APH1B
KALRN
OSBPL5
OSBPL8
LXN
GRP
RARRES1
KCNA10
TSPAN13
PLEKHG4
Olfactory Signaling Pathway | Signal transduction
Nuclear Receptor transcription pathway | Gene expression (Transcription)
Sensory Perception | Sensory perception
SUMOylation of intracellular receptors | Metabolism of proteins
Prasterone
Prednisolone*$
Codeine
Gallium citrate Ga 67
Drostanolone
Pravastatin*
Gonadorelin*
Prednisone*$
Ifosfamide
Estriol
Tetrahydrofolic acid
Pomalidomide
Vindesine
Medrogestone
Magnesium carbonate
Hydrocortisone*$
Tibolone
Cabazitaxel
Lactulose*
Fludrocortisone*
Betamethasone*
Levonorgestrel*
Drostanolone
Prednisolone*$
Citric Acid
Mometasone$
Norelgestromin
Carboplatin*
Deflazacort
Gestodene
Calcidiol
Triamcinolone*
Exemestane
Fluorometholone
Carboprost Tromethamine
Gestrinone
Alprostadil
Fluticasone furoate
Ergocalciferol*
Tixocortol
Ocular symptomsauditory system disease
ocular hyperemia
amblyopia
suppression amblyopia
Brown's tendon sheath syndrome
internuclear ophthalmoplegia
ocular motility disease
low tension glaucoma
primary open angle glaucoma
residual stage of open angle glaucoma
borderline glaucoma
chronic closed-angle glaucoma
primary angle-closure glaucoma
residual stage angle-closure glaucoma
acute closed-angle glaucoma
interval angle-closure glaucoma
aqueous misdirection
hypersecretion glaucoma
optic nerve disease
central sleep apnea
eye accommodation disease
eye disease
glaucoma
open-angle glaucoma
Foster-Kennedy syndrome
retinal disease
central nervous system origin vertigo
cycloplegia
retinitis pigmentosa
retinal degeneration
ocular hypertension
NR4A3
NR3C2
KCNA10
NR3C1
OSBPL5
OSBPL8
PGR
SLC8A3
TSPAN13
ANXA1
NUP107
ARFGEF2
GRP
ELOVL7
SLC8A1
TMEM86B
ELOVL1
ARFGEF1
COX7A2L
COX7A1
Nuclear Receptor transcription pathway | Gene expression (Transcription)
SUMOylation of intracellular receptors | Metabolism of proteins
Reduction of cytosolic Ca++ levels | Hemostasis
Sodium/Calcium exchangers | Transport of small molecules
Noncanonical activation of NOTCH3 | Signal transduction
PP2A-mediated dephosphorylation of key metabolic factors | Metabolism
Molecules associated with elastic fibres | Extracellular matrix organization
E2F mediated regulation of DNA replication | Cell cycle
Prednisolone*$
Framycetin
Dicloxacillin
Piperacillin$
Prednisone*$
Prasterone
Amikacin
Hydrocortisone*$
Fludrocortisone
Tafluprost*
Gentamicin*
Pefloxacin
Lomefloxacin
Codeine
Demecarium
Kanamycin
Travoprost*
Amoxicillin*$
Carbachol
Viomycin
Diflorasone
Betamethasone*
Clocortolone
Clobetasone
Levonorgestrel*
Deflazacort
Prednisolone*$
Alitretinoin
Ulobetasol
Mometasone*$
Alclometasone
Fluticasone* furoate
Triamcinolone*
Desoximetasone
Fluorometholone*
Loteprednol*
Carboplatin*
Gestodene
Norelgestromin
Exemestane
Respiratoryupper respiratory tract disease
lower respiratory tract disease
vasomotor rhinitis
allergic asthma
intrinsic asthma
croup
asthma
chronic rhinitis
status asthmaticus
pulmonary emphysema
obstructive lung disease
rhinitis
pulmonary fibrosis
adult respiratory distress syndrome
nasopharyngitis
maple bark strippers' lung
cork-handlers' disease
mushroom workers' lung
malt worker's lung
farmer's lung
bird fancier's lung
bagassosis
ventilation pneumonitis
chronic obstructive pulmonary disease
lymphangioleiomyomatosis
bronchiolitis
tonsillitis
pulmonary edema
respiratory failure
lung disease
COX7A1
COX7A2L
COX7A2
NR4A3
ELOVL7
ELOVL1
ANXA1
NR3C2
NR3C1
OSBPL8
TSPAN13
OSBPL5
PRLR
ITGB6
APH1B
ITGB7
ITGB5
OR5AK2
LXN
IL22RA2
Nuclear Receptor transcription pathway | Gene expression (Transcription)
Olfactory Signaling Pathway | Signal transduction
Na+/Cl- dependent neurotransmitter transporters | Transport of small molecules
Class A/1 (Rhodopsin-like receptors) | Signal transduction
Amine ligand-binding receptors | Signal transduction
Peptide ligand-binding receptors | Signal transduction
ADORA2B mediated anti-inflammatory cytokines production | Disease
G alpha (s) signalling events | Signal transduction
Relaxin receptors | Signal transduction
Noncanonical activation of NOTCH3 | Signal transduction
PP2A-mediated dephosphorylation of key metabolic factors | Metabolism
Prednisolone*$
Codeine*
Dicloxacillin
Piperacillin*$
Caffeine*
Pefloxacin
Ipratropium* bromide
Prasterone
Kanamycin
Lomefloxacin
Amoxicillin*$
Pravastatin
Viomycin
Ampicillin*
Ceftizoxime
Temazepam*
Cefradine
Cefpodoxime
Cefmenoxime
Fludrocortisone
Betamethasone*
Deflazacort
Levonorgestrel
Citric* Acid
Prednisolone*$
Modafinil*
Mometasone*$
Fluticasone* furoate
Drostanolone
Mephentermine
Digoxin*
Triamcinolone*
Fluorometholone
Amphetamine
Exemestane
Salbutamol*
Imipramine
Calcidiol
Norelgestromin
Gestodene
Hepatocellular injury/Acute hepatitis/liver failurebiliary dyskinesia
acalculous cholecystitis
cholecystitis
choledocholithiasis
acute pancreatitis
hepatorenal syndrome
postgastrectomy syndrome
alcoholic liver cirrhosis
liver disease
pancreatic steatorrhea
strawberry gallbladder
postcholecystectomy syndrome
hydrops of gallbladder
occlusion of gallbladder
ascending cholangitis
suppurative cholangitis
perforation of bile duct
coronary artery disease
cholelithiasis
cholecystolithiasis
blind loop syndrome
dumping syndrome
gallbladder disease
primary biliary cirrhosis
drug-induced hepatitis
intrahepatic cholestasis
short bowel syndrome
liver cirrhosis
pancreatitis
CX3CR1
OR51V1
CMKLR1
CCR5
CCR2
CHRM3
GPR132
GPR32
OR4K5
OR10G7
CHRM5
CCRL2
CHRM1
CCR1
OR51E2
OR2J2
OR10H5
OR4N2
OR10S1
OR5C1
Olfactory Signaling Pathway | Signal transduction
APC truncation mutants have impaired AXIN binding | Disease
AXIN missense mutants destabilize the destruction complex | Disease
Truncations of AMER1 destabilize the destruction complex | Disease
Signaling by APC mutants | Disease
Signaling by GSK3beta mutants | Disease
Signaling by AMER1 mutants | Disease
Signaling by AXIN mutants | Disease
Signaling by CTNNB1 phospho-site mutants | Disease
T41 mutants of beta-catenin aren't phosphorylated | Disease
S33 mutants of beta-catenin aren't phosphorylated | Disease
S45 mutants of beta-catenin aren't phosphorylated | Disease
S37 mutants of beta-catenin aren't phosphorylated | Disease
Chemokine receptors bind chemokines | Signal transduction
Beta-catenin phosphorylation cascade | Signal transduction
Platelet sensitization by LDL | Hemostasis
CTLA4 inhibitory signaling | Immune system
Sensory Perception | Sensory perception
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | Cell cycle
Amplification of signal from the kinetochores | Cell cycle
Muscarinic acetylcholine receptors | Signal transduction
Disassembly of the destruction complex and recruitment of AXIN to the membrane | Signal transduction
G beta:gamma signalling through BTK | Signal transduction
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | Cell cycle
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | Gene expression (Transcription)
G beta:gamma signalling through CDC42 | Signal transduction
Degradation of beta-catenin by the destruction complex | Signal transduction
PP2A-mediated dephosphorylation of key metabolic factors | Metabolism
Mitotic Spindle Checkpoint | Cell cycle
Class A/1 (Rhodopsin-like receptors) | Signal transduction
G beta:gamma signalling through PLC beta | Signal transduction
Prostacyclin signalling through prostacyclin receptor | Hemostasis
Presynaptic function of Kainate receptors | Neuronal system
Signaling by WNT in cancer | Disease
Trafficking and processing of endosomal TLR | Immune system
Codeine
Prasterone
Drostanolone
Lactulose
Prednisolone$
Gonadorelin
Cabazitaxel
Paclitaxel
Ifosfamide
Pravastatin
Tibolone
Naltrexone$
Tetrahydrofolic acid
Erlotinib
Docetaxel
Methylscopolamine bromide
Idarubicin
Mepivacaine
Estriol
Temazepam
Ipratropium bromide
Propantheline
Trihexyphenidyl
Cisatracurium besylate
Cevimeline
Drostanolone
Naltrexone$
Oxyphencyclimine
Meclizine
Levomethadyl Acetate
Amphetamine
Methadone
Imipramine
Metixene
Mivacurium
Mephentermine
Solifenacin
Buprenorphine
Levonorgestrel
Tiotropium
Renal/Acute kidney failure injurygynecomastia
premenstrual tension
female reproductive system disease
kidney hypertrophy
non-congenital cyst of kidney
pyeloureteritis cystica
impaired renal function disease
nephrosclerosis
ureterolithiasis
enterocele
breast fibrocystic disease
nephrolithiasis
urethral disease
endometriosis
chronic interstitial cystitis
interstitial cystitis
SLC8A3
ELOVL7
NR4A3
KCNA10
ELOVL1
RARRES3
LXN
PLEKHG4
HRASLS5
COX7A2L
COX7A2
COX7A1
ELOVL4
PLA2G16
FAM84A
FAM84B
NR0B1
KALRN
OSBPL8
OSBPL5
Nuclear Receptor transcription pathway | Gene expression (Transcription)
The canonical retinoid cycle in rods (twilight vision) | Signal transduction
Acyl chain remodelling of PS | Metabolism
Small interfering RNA (siRNA) biogenesis | Gene expression (Transcription)
Dicloxacillin
Piperacillin*$
Pefloxacin
Lomefloxacin
Viomycin
Amoxicillin*$
Kanamycin
Cefradine
Ceftizoxime
Cefmenoxime
Cefprozil
Ampicillin*
Cephalexin*
Ceftibuten*
Cefoperazone
Cefpiramide
Cefmetazole
Cefaclor
Cefamandole
Cefapirin
Levonorgestrel
Citric* Acid
Betamethasone
Calcidiol*
Norelgestromin
Drostanolone
Prednisolone*$
Ergocalciferol*
Glimepiride*
Exemestane*
Carboplatin*
Gestrinone
Gestodene
Mometasone$
Medrogestone
Dienogest
Carboprost Tromethamine
Methylscopolamine bromide
Triamcinolone
Alprostadil*
Cerebral ischemia/infarctioncarotid stenosis
brain ischemia
renal artery disease
arteriosclerosis obliterans
aortic aneurysm
abdominal aortic aneurysm
intracranial embolism
peripheral vascular disease
lymphedema
thromboangiitis obliterans
thoracic aortic aneurysm
cerebral arterial disease
cerebrovascular disease
varicose veins
PTGDR2
APLNR
F2RL2
GPR25
CXCR6
XCR1
GALR1
OR12D2
ADRB3
OR52B4
GPR55
SUCNR1
CCR9
BRS3
NPY2R
TACR2
ADRB2
OR5M10
GALR3
OR5M1
Class A/1 (Rhodopsin-like receptors) | Signal transduction
GPCR ligand binding | Signal transduction
Peptide ligand-binding receptors | Signal transduction
GPCR downstream signalling | Signal transduction
Signaling by GPCR | Signal transduction
ADORA2B mediated anti-inflammatory cytokines production | Disease
G alpha (s) signalling events | Signal transduction
Amine ligand-binding receptors | Signal transduction
Anti-inflammatory response favouring Leishmania parasite infection | Disease
Leishmania parasite growth and survival | Disease
Adrenoceptors | Signal transduction
G alpha (i) signalling events | Signal transduction
Tachykinin receptors bind tachykinins | Signal transduction
Relaxin receptors | Signal transduction
Leishmania infection | Disease
Chemokine receptors bind chemokines | Signal transduction
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | Disease
G alpha (q) signalling events | Signal transduction
Codeine
Acarbose
Paliperidone
Trandolapril
Naltrexone$
Prasterone
Ramipril$
Cabazitaxel
Mepivacaine
Reserpine
Pravastatin
Lactulose
Caffeine
Prednisolone$
Enalapril
Temazepam
Medrogestone
Betaxolol
Gonadorelin
Pindolol
Naltrexone$
Salbutamol
Mephentermine
Modafinil
Imipramine
Timolol
Orciprenaline
Buprenorphine
Epirubicin
Betaxolol
Morphine$
Tolazoline
Codeine
Amphetamine
Trihexyphenidyl
Oxprenolol
Levallorphan
Amitriptyline
Bisoprolol
Drostanolone
Acute myocardial infarctionacute anterolateral myocardial infarction
acute inferolateral myocardial infarction
acute inferoposterior infarction
subendocardial infarction acute myocardial infarction
strictly posterior acute myocardial infarction
intermediate coronary syndrome
acute myocardial infarction
myocardial infarction
coronary artery disease
coronary artery vasospasm
ADRB3
SLC6A16
SLC6A5
SLC6A20
SLC6A7
SLC6A14
SLC6A9
TACR2
OR5M1
SLC6A15
APLNR
OR52B4
SLC6A6
SLC6A13
ADRB2
SLC6A12
OR52N2
YARS2
TAAR9
TAAR6
Class A/1 (Rhodopsin-like receptors) | Signal transduction
Amine ligand-binding receptors | Signal transduction
GPCR ligand binding | Signal transduction
GPCR downstream signalling | Signal transduction
Adrenoceptors | Signal transduction
Signaling by GPCR | Signal transduction
Olfactory Signaling Pathway | Signal transduction
Peptide ligand-binding receptors | Signal transduction
ADORA2B mediated anti-inflammatory cytokines production | Disease
G alpha (s) signalling events | Signal transduction
Na+/Cl- dependent neurotransmitter transporters | Transport of small molecules
Dopamine receptors | Signal transduction
TWIK-releated acid-sensitive K+ channel (TASK) | Neuronal system
Sensory Perception | Sensory perception
Opsins | Signal transduction
G alpha (i) signalling events | Signal transduction
Anti-inflammatory response favouring Leishmania parasite infection | Disease
Leishmania parasite growth and survival | Disease
G alpha (q) signalling events | Signal transduction
Adrenaline signalling through Alpha-2 adrenergic receptor | Hemostasis
Tachykinin receptors bind tachykinins | Signal transduction
Histamine receptors | Signal transduction
Serotonin receptors | Signal transduction
Trandolapril
Prednisolone*$
Codeine
Paliperidone
Ramipril*$
Enalapril
Temazepam
Pravastatin*
Prasterone
Trihexyphenidyl
Caffeine*
Orphenadrine
Betaxolol
Medrogestone
Methylscopolamine bromide
Estriol
Reserpine
Nimodipine
Epinephrine*
Pindolol
Modafinil
Mephentermine
Pinaverium
Salbutamol
Tiagabine
Amphetamine
Tolazoline
Orciprenaline
Imipramine*
Betaxolol
Citalopram*
Pseudoephedrine
Epirubicin
Trihexyphenidyl
Timolol
Oxprenolol
Selegiline
Mirabegron
Bisoprolol*
Naltrexone*$
Hematologicmethemoglobinemia
hemorrhagic disease
lymphopenia
hypersplenism
myofascial pain syndrome
autoimmune lymphoproliferative syndrome
sickle cell anemia
platelet storage pool deficiency
COX7A2L
COX7A1
COX7A2
SLC8A3
ELOVL7
NR4A3
ELOVL1
ELOVL4
SLC8A1
APH1B
OR2A1
GPR4
RARRES1
KALRN
CELA2B
PTGER1
SF3B1
APH1A
SHBG
MC1R
Olfactory Signaling Pathway | Signal transduction
Nuclear Receptor transcription pathway | Gene expression (Transcription)
Class A/1 (Rhodopsin-like receptors) | Signal transduction
Sensory Perception | Sensory perception
Na+/Cl- dependent neurotransmitter transporters | Transport of small molecules
Eicosanoid ligand-binding receptors | Signal transduction
Peptide ligand-binding receptors | Signal transduction
GPCR ligand binding | Signal transduction
Prostanoid ligand receptors | Signal transduction
Adenosine P1 receptors | Signal transduction
Histamine receptors | Signal transduction
Prasterone
Prednisolone*$
Codeine*
Drostanolone
Pomalidomide*
Vindesine
Ifosfamide*
Cabazitaxel*
Pravastatin*
Tetrahydrofolic acid
Paliperidone
Temazepam
Gonadorelin
Methylscopolamine bromide
Orphenadrine
Medrogestone
Everolimus*
Prednisone*$
Estriol*
Regorafenib*
Drostanolone
Levonorgestrel*
Betamethasone
Modafinil*
Imipramine
Naltrexone$
Prednisolone*$
Mephentermine
Tolazoline
Carboplatin*
Carboprost Tromethamine
Amphetamine
Trihexyphenidyl
Alprostadil
Mometasone*$
Citalopram
Calcidiol
Ergocalciferol
Testosterone*$
Buprenorphine*
Showing 1 to 10 of 21 entries

Copyright © 2025 · Minimum Pro on Genesis Framework · WordPress · Log in